Ilya Pharma AB - Developing the next-generation biological drugs for treating wounds in skin and mucosa.
Location: Sweden, Uppsala
Investors 1
| Date | Name | Website |
| - | Stockholms... | stoaf.se |
Mentions in press and media 12
| Date | Title | Description |
| 01.04.2025 | Ilya Pharma publishes data on potent bacterial killing effect by ILP100 on totally resistant bacterial pathogens from Ukrainian war victims | Ilya Pharma publishes data on potent bacterial killing effect by ILP100 on totally resistant bacterial pathogens from Ukrainian war victims Tue, Apr 01, 2025 15:10 CET Report this content Uppsala, April 1, 2025: Ilya Pharma (the Company), a... |
| 07.02.2025 | Ilya Pharma CEO selected for Eisenhower Fellowship named after American President Dwight D. Eisenhower to promote global peace and development | Ilya Pharma CEO selected for Eisenhower Fellowship named after American President Dwight D. Eisenhower to promote global peace and development Fri, Feb 07, 2025 08:43 CET Report this content Uppsala, February 6, 2025: Ilya Pharma (the Compa... |
| 11.09.2024 | Ilya Pharma receives Rare Pediatric Disease Designation from the U.S. FDA for emilimogene sigulactibac for the treatment of skin wounds in SAVI patients | Ilya Pharma receives Rare Pediatric Disease Designation from the U.S. FDA for emilimogene sigulactibac for the treatment of skin wounds in SAVI patients Wed, Sep 11, 2024 14:57 CET Report this content Local-acting immunotherapies using bact... |
| 12.05.2023 | Hello Tomorrow is bridging the gap between deep tech and entrepreneurship to foster world changing tech | The last few years have brought a strong increase in scientific startups. They typically come with some distinct advantages – clever teams, initial hypotheses are proven, and ideas that have been subject to academic rigour and peer reviews.... |
| 13.09.2022 | Ilya Pharma presents first in class wound healing treatment at US Defense Department’s MHSRS 2022 Conference in Florida | Ilya Pharma presents first in class wound healing treatment at US Defense Department’s MHSRS 2022 Conference in Florida Tue, Sep 13, 2022 08:43 CET Report this content ILP100 accelerates wound healing in humans and suited for use in unconve... |
| 23.05.2022 | Ilya Pharma extends global patent coverage for ILP100 for the treatment of diseases of skin and mucosa in humans and animals | Ilya Pharma extends global patent coverage for ILP100 for the treatment of diseases of skin and mucosa in humans and animals Mon, May 23, 2022 09:50 CET Report this content Low manufacturing costs, excellent temperature stability and high e... |
| 04.05.2022 | Ilya Pharma announces FDA clearance of IND for first-in-class ILP100-Topical immunotherapy treatment of surgical wounds in patients with prediabetes, diabetes and obesity | Ilya Pharma announces FDA clearance of IND for first-in-class ILP100-Topical immunotherapy treatment of surgical wounds in patients with prediabetes, diabetes and obesity Wed, May 04, 2022 08:30 CET Report this content Uppsala, May 4, 2022:... |
| 03.05.2022 | Ilya Pharma strengthens board with appointments of corporate development specialist Hughes Crameri and Galderma veteran Carson | Ilya Pharma strengthens board with appointments of corporate development specialist Hughes Crameri and Galderma veteran Carson Tue, May 03, 2022 08:00 CET Report this content Uppsala, May 3, 2022: Ilya Pharma (the Company), a clinical stage... |
| 19.04.2022 | Ilya Pharma makes strategic investment in bioanalytical company Nordic Bioanalysis to strengthen supply chain | Ilya Pharma makes strategic investment in bioanalytical company Nordic Bioanalysis to strengthen supply chain Tue, Apr 19, 2022 11:30 CET Report this content Located at the previous Astra Zeneca site in Södertälje, south of Stockholm, Nordi... |
| 12.01.2022 | Ilya Pharma announces plan for clinical development of ILP100-Oral targeting cancer treatment mediated enterocolitis | Ilya Pharma announces plan for clinical development of ILP100-Oral targeting cancer treatment mediated enterocolitis Wed, Jan 12, 2022 07:00 CET Growing unmet need in immune checkpoint inhibitor induced colitis drives urgent need for local ... |
Show more